- South Korea
- /
- Healthcare Services
- /
- KOSDAQ:A032940
There May Be Underlying Issues With The Quality Of Wonik's (KOSDAQ:032940) Earnings
Wonik Corporation's (KOSDAQ:032940) robust earnings report didn't manage to move the market for its stock. We did some digging, and we found some concerning factors in the details.
An Unusual Tax Situation
We can see that Wonik received a tax benefit of ₩28b. This is meaningful because companies usually pay tax rather than receive tax benefits. Of course, prima facie it's great to receive a tax benefit. And given that it lost money last year, it seems possible that the benefit is evidence that it now expects to find value in its past tax losses. However, the devil in the detail is that these kind of benefits only impact in the year they are booked, and are often one-off in nature. In the likely event the tax benefit is not repeated, we'd expect to see its statutory profit levels drop, at least in the absence of strong growth. While we think it's good that the company has booked a tax benefit, it does mean that there's every chance the statutory profit will come in a lot higher than it would be if the income was adjusted for one-off factors.
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Wonik.
Our Take On Wonik's Profit Performance
In its most recent report, Wonik disclosed a tax benefit, as we discussed above. Given that sort of benefit is not recurring, it's safe to say the statutory profit overstates its underlying profitability quite significantly. For this reason, we think that Wonik's statutory profits may be a bad guide to its underlying earnings power, and might give investors an overly positive impression of the company. On the bright side, the company showed enough improvement to book a profit this year, after losing money last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. For example, we've found that Wonik has 3 warning signs (1 doesn't sit too well with us!) that deserve your attention before going any further with your analysis.
This note has only looked at a single factor that sheds light on the nature of Wonik's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
Valuation is complex, but we're here to simplify it.
Discover if Wonik might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KOSDAQ:A032940
Wonik
Engages in the semiconductor, trade and distribution, finance, cosmetics, IT and electronic parts, robots, and leisure businesses in South Korea.
Adequate balance sheet and fair value.
Market Insights
Community Narratives
